Santen has signed an agreement with RemeGen for the RC28-E intravitreal injection, a dual-target fusion protein for retinal diseases.

Danish big pharma Novo Nordisk has been given the go-ahead for its star weight loss drug, Wegovy (semaglutide), in patients with metabolic dysfunction-associated steatohepatitis (MASH) who have ...

Fosun and Expedition make $645m licensing deal for respiratory drug Fosun Pharma will retain the rights to develop, manufacture and commercialise XH-S004 in some specific regions.

Trump targets bolstering of US emergency drug reserve The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.

Concerns around Ixchiq's safety profile in elderly individuals continue as travel-related chikungunya cases increase in the UK.

RFK Jr’s mRNA funding halt signals “shift in US public health” The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

The FDA has approved a label expansion to Teva’s Ajovy in certain children and adolescents, making it the first migraine prevention drug of its kind in the age group.

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North Chicago, Illinois.

MAXONA Pharmaceuticals has submitted an IND application seeking approval from the US FDA for its lead compound, MAX-001, to treat acute pain.

WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

Uncertainty looms over FDA scheme to boost US manufacturing The FDA’s new PreCheck programme is aimed at facilitating the introduction of new US drug manufacturing facilities.

Gilead's PrEP Yeztugo is set to become the pharma's star asset, with GlobalData forecasting of just under $5bn in 2031.